Harley-Davidson Inc
Change company Symbol lookup
Select an option...
HOG Harley-Davidson Inc
FRME First Merchants Corp
SFDMY Shanghai Fudan Microelectronics Group Co Ltd
NWL Newell Brands Inc
MRK Merck & Co Inc
FWONA Liberty Media Corp
RSG Republic Services Inc
TENB Tenable Holdings Inc
NLSN Nielsen Holdings PLC
CLAR Clarus Corp
Go

Consumer Discretionary : Automobiles | Small Cap Blend
Company profile

Harley-Davidson, Inc. is the parent company for the groups of companies doing business as Harley-Davidson Motor Company (HDMC) and Harley-Davidson Financial Services (HDFS). The Company operates through two segments: Motorcycles and Related Products (Motorcycles) and Financial Services. The Motorcycles segment consists of HDMC, which designs, manufactures and sells Harley-Davidson motorcycles as well as motorcycle parts, accessories, general merchandise and services. The Company's products are sold to retail customers primarily through a network of independent dealers. The Financial Services segment consists of HDFS, which is engaged in the business of financing and servicing wholesale inventory receivables and retail consumer loans, primarily for the purchase of Harley-Davidson motorcycles. HDFS also works with certain unaffiliated insurance companies to provide motorcycle insurance and protection products to motorcycle owners.

Closing Price
$37.40
Day's Change
-1.41 (-3.63%)
Bid
--
Ask
--
B/A Size
--
Day's High
37.77
Day's Low
36.80
Volume
(Light)
Volume:
789,845

10-day average volume:
1,139,300
789,845

Flora Growth Signs Letter of Intent to Enter Panama, Applauds Recent Cannabis Law Reforms

7:05 am ET September 16, 2021 (BusinessWire) Print

Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that Flora Growth has entered into a non-binding Letter of Intent ("LOI") with Robust Farms Inc. ("Robust"), a Panamanian importer and distributor, to supply its premium cannabidiol ("CBD") derivative products from its Kasa Wholefoods division. Additionally, Robust will be applying for its import license of cannabis products which Flora expects to ship its medical-grade cannabis products upon receipt of this updated licensing.

On August 30th, Panama's National Legislative Assembly passed Bill 153 to legalize the use of medical cannabis and its therapeutic properties. It's expected that Panama will become the first country in Central America to regulate the use of medical cannabis, however, the new regulations must be approved by President Laurentino Cortizo. The new law aims to promote and ensure monitored and controlled access to medical cannabis products by working with a number of government divisions and agencies. Some key highlights of the new legislation include:

Patients that have been authorized to use medical cannabis based on specific clinical indications will have the right to access medical cannabis products through licensed pharmacies Domestic production will take place, though only seven licenses for the manufacturing of cannabis seeds, plants, and derivatives will be granted Pharmacies will be responsible for the distribution of medical cannabis products and will need to apply for a permit and pass a site inspection (valid initially for two years) The creation of the National Program for the Study of the Medicinal Use of Cannabis and its Derivatives to promote research and develop educational campaigns There is no provision for at home cultivation Advertising may only appear in scientific journals, not the media or social networks

"It's important to recognize the continued trend of medical and adult-use cannabis legalization sweeping across the globe as governments increasingly recognize its therapeutic properties, and want to control, regulate, and tax these products to foster economic prosperity, as well as bring significant reform in civil rights and criminal justice," said Luis Merchan, President and CEO of Flora Growth. "We applaud the efforts of Panamanian legislators and advocacy groups to push forward this initiative that will ultimately help provide options for patients who are looking to improve their quality of life by utilizing emerging cannabinoid therapeutic treatments and look forward to working with local partners to provide our medical-grade cannabis products to the citizens of Panama."

"We're extremely pleased to enter into this agreement with Flora in order to pre-emptively secure access to their medical-grade cannabis products - which we believe is the first of its kind to be announced since the cannabis legislation passed - and look forward to supplying our clients with Flora's premium portfolio of CBD-infused and non-CBD food and beverage products in the short term," said Maurice Holmes Mendez, CEO of Robust. "While the new proposed framework awaits signature from the President, our team is hard at work building out our traditional and medical cannabis sales channels in the LATAM region, which relies heavily on working with experienced business partners and healthcare practitioners."

Upcoming CEO Fireside Chat

Flora is also pleased to announce that it will be hosting another live fireside discussion between President & CEO, Luis Merchan, Chief Revenue Officer, Jason Warnock, and Vice President of Corporate Development, James Williams. The virtual fireside conversation will take place Tuesday, September 21st at 1:00 pm ET, and all those interested in attending are encouraged to register using the following link.

Registration Link:

https://us02web.zoom.us/webinar/register/WN_eRv8cruzS66PSh6FvOV4hA

Specifically, Luis, Jason, and James will provide an overview of the recent Colombian legislative changes and timeline, including discussing the receipt of our export quota, international markets, and our near-term and long-term international product roadmap. An update will be provided regarding the proposed acquisition of Vessel Brand and the closing of our investment into Hoshi International, including their strategic importance to Flora's international expansion, human capital, and anticipated contribution to revenue growth. Lastly, management will provide an operational update regarding activities at Cosechemos and Flora Lab, including a discussion around specific steps to commercialize our products for export.

About Flora Growth Corp.

Flora is a cannabis company that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive. Visit www.floragrowth.ca or follow @floragrowthcorp on social for more information.

Cautionary Statement Concerning Forward-Looking Statements

This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: Flora's supply chain strategy; the size of markets for cannabis and cannabis products; our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, or the forward-looking events discussed in this document and other statements made from time to time by us or our representatives not occurring, except as may be required by applicable law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210916005333/en/

SOURCE: Flora Growth Corp.

Investor Relations Contact:
Evan Veryard
evan.veryard@floragrowth.ca

Public Relations Contact: 
Cassandra Dowell
+1 (858) 264-6600
flora@cmwmedia.com
comtex tracking

COMTEX_393443776/1006/2021-09-16T07:05:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.